Know Cancer

or
forgot password

Contrast Enhanced EUS Using Definity in the Evaluation of Pancreatic Cancer and Pancreatic Masses


N/A
21 Years
N/A
Not Enrolling
Both
Pancreatic Cancer

Thank you

Trial Information

Contrast Enhanced EUS Using Definity in the Evaluation of Pancreatic Cancer and Pancreatic Masses


Inclusion Criteria:



- Consecutive patients over a 1-year period referred for EUS examination due to
suspected pancreatic lesions will be enrolled.

- Age 21 years and above.

- Ability to provide informed consent

Exclusion Criteria:

Patients with clinical conditions that preclude the use of DEFINITY™ will be excluded.
These conditions are:

- Right-to-left, bi-directional, or transient right-to-left cardiac shunts;

- Worsening or clinically unstable congestive heart failure;

- Acute myocardial infarction or acute coronary syndromes;

- Serious ventricular arrhythmias or high risk for arrhythmias due to prolongation of
the QT interval;

- Respiratory failure;

- Severe emphysema, pulmonary emboli or other conditions that cause pulmonary
hypertension due to compromised pulmonary arterial vasculature;

- Hypersensitivity to DEFINITY™ or its components.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Authority:

Singapore: Health Sciences Authority

Study ID:

CTC0900328

NCT ID:

NCT01703026

Start Date:

August 2009

Completion Date:

October 2011

Related Keywords:

  • Pancreatic Cancer
  • Pancreatic Neoplasms

Name

Location